搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
5 小时
on MSN
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
3 天
Tirzepatide outpacing Wegovy in the obesity space
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...
FiercePharma
3 天
Lilly’s Zepbound expected to surpass Novo’s Wegovy to ‘dominate’ obesity market ...
Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it ...
2 天
Could Trump Make A Big Weight Loss Drug Deal?
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
6 天
on MSN
Clalit joins Meuhedet, Maccabi in subsidizing weight loss shot Wegovy
This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.
3 天
on MSN
West Virginia patients are left in limbo over changing insurance coverage of obesity ...
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...
10 小时
Regeneron's Diversified Growth Makes It My Top Biopharma Pick For 2025
Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...
dailymemphian
5 天
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Opinion
BioSpace
2 天
Opinion
Opinion: Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈